Outcomes in liver transplantation: Does sex matter?

Journal of Hepatology

Volumn 62, Issue 4, 2015, Pages 946-955

  Sarkar, Monika ^a   Watt, Kymberly D ^b   Terrault, Norah ^a   Berenguer, Marina ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Hepatitis C virus; Liver allocation; Liver transplantation; MELD score; Quality of life; Sex; Waitlist outcome; Women's health

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERFERON; RIBAVIRIN;

ACUTE LIVER FAILURE; ALCOHOL LIVER DISEASE; ANEMIA; AUTOIMMUNE HEPATITIS; ETHNICITY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE COST; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MORTALITY; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SARCOPENIA; SEX DIFFERENCE; SIDE EFFECT; ADVERSE EFFECTS; END STAGE LIVER DISEASE; FEMALE; HOSPITAL ADMISSION; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION;

END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; SEX FACTORS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84926420052     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.023     Document Type: Review

References (136)

1. In: Scientific registry of transplant recipients.
2. C.L. Bryce, C.C. Chang, D.C. Angus, R.M. Arnold, M. Farrell, and M.S. Roberts The effect of race, sex, and insurance status on time-to-listing decisions for liver transplantation J Transplant 2010 2010 467976
3. P.J. Thuluvath, M.K. Guidinger, J.J. Fung, L.B. Johnson, S.C. Rayhill, and S.J. Pelletier Liver transplantation in the United States, 1999-2008 Am J Transplant 10 2010 1003 1019
4. H.C. Hermann, B.F. Klapp, G. Danzer, and C. Papachristou Gender-specific differences associated with living donor liver transplantation: a review study Liver Transpl 16 2010 375 386
5. R.B. Freeman Jr., R.H. Wiesner, A. Harper, S.V. McDiarmid, J. Lake, and E. Edwards The new liver allocation system: moving toward evidence-based transplantation policy Liver Transpl 8 2002 851 858
6. A.L. Mindikoglu, S.H. Emre, and L.S. Magder Impact of estimated liver volume and liver weight on gender disparity in liver transplantation Liver Transpl 19 2013 89 95
7. C.A. Moylan, C.W. Brady, J.L. Johnson, A.D. Smith, J.E. Tuttle-Newhall, and A.J. Muir Disparities in liver transplantation before and after introduction of the MELD score JAMA 300 2008 2371 2378
8. P. Sharma, D.E. Schaubel, E.E. Messersmith, M.K. Guidinger, and R.M. Merion Factors that affect deceased donor liver transplantation rates in the United States in addition to the model for end-stage liver disease score Liver Transpl 18 2012 1456 1463
9. A.K. Mathur, D.E. Schaubel, Q. Gong, M.K. Guidinger, and R.M. Merion Sex-based disparities in liver transplant rates in the United States Am J Transplant 11 2011 1435 1443
10. D.A. Axelrod, N. Dzebisashvili, K. Lentine, D.L. Segev, R. Dickson, and E. Tuttle-Newhall Assessing variation in the costs of care among patients awaiting liver transplantation Am J Transplant 14 2014 70 78
11. A.K. Mathur, V.B. Ashby, D.S. Fuller, M. Zhang, R.M. Merion, and A. Leichtman Variation in access to the liver transplant waiting list in the United States Transplantation 98 2014 94 99
12. R.P. Myers, A.A. Shaheen, A.I. Aspinall, R.R. Quinn, and K.W. Burak Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate J Hepatol 54 2011 462 470
13. J.C. Lai, N.A. Terrault, E. Vittinghoff, and S.W. Biggins Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system Am J Transplant 10 2010 2658 2664
14. S.C. Huo, T.I. Huo, H.C. Lin, C.W. Chi, P.C. Lee, and F.W. Tseng Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation? Transplantation 84 2007 1406 1412
15. E. Cholongitas, L. Marelli, A. Kerry, M. Senzolo, D.W. Goodier, and D. Nair Different methods of creatinine measurement significantly affect MELD scores Liver Transpl 13 2007 523 529
16. L.A. Fussner, M.R. Charlton, J.K. Heimbach, C. Fan, R. Dierkhising, and E. Coss The impact of gender and NASH on chronic kidney disease before and after liver transplantation Liver Int 34 2014 1259 1266 10.1111/liv.12381
17. A.L. Mindikoglu, A. Regev, S.L. Seliger, and L.S. Magder Gender disparity in liver transplant waiting-list mortality: the importance of kidney function Liver Transpl 16 2010 1147 1157
18. A.L. Mindikoglu, J.P. Raufman, S.L. Seliger, C.D. Howell, and L.S. Magder Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis Transplant Proc 43 2011 2669 2677
19. A.L. Mindikoglu, L.S. Madger, S.L. Seliger, J.P. Raufman, and C.D. Howell Outcomes and predictors of simultaneous liver-kidney transplantation among patients with kidney dysfunction who are not on dialysis on the liver transplant waiting list Gastroenterology 138 2010 S-774
20. H. Bruns, V.J. Lozanovski, D. Schultze, N. Hillebrand, U. Hinz, and M.W. Buchler Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis PLoS One 9 2014 e98782
21. A.K. Mathur, D.E. Schaubel, H. Zhang, M.K. Guidinger, and R.M. Merion Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex Transplantation 97 2014 862 869
22. V.K. Rustgi, G. Marino, M.T. Halpern, L.B. Johnson, W.O. Umana, and C. Tolleris Role of gender and race mismatch and graft failure in patients undergoing liver transplantation Liver Transpl 8 2002 514 518
23. E. Velidedeoglu, K.C. Mange, A. Frank, P. Abt, N.M. Desai, and J.W. Markmann Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients Transplantation 77 2004 1834 1842
24. D. Fairweather, S. Frisancho-Kiss, and N.R. Rose Sex differences in autoimmune disease from a pathological perspective Am J Pathol 173 2008 600 609
25. C. Benitez, M.C. Londono, R. Miquel, T.M. Manzia, J.G. Abraldes, and J.J. Lozano Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients Hepatology 58 2013 1824 1835
26. Y. Sanada, Y. Kawano, A. Miki, J. Aida, K. Nakamura, and N. Shimomura Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia Transpl Int 27 2014 383 390
27. K. Waki, Y. Sugawara, K. Mizuta, H. Fujita, T. Kadowaki, and N. Kokudo Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance Clinical Transplants 2011 223 235
28. R.A. McTaggart, N.A. Terrault, A.J. Vardanian, A. Bostrom, and S. Feng Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation Liver Transpl 10 2004 975 985
29. P.H. Thurairajah, M. Carbone, H. Bridgestock, P. Thomas, S. Hebbar, and B.K. Gunson Late acute liver allograft rejection; a study of its natural history and graft survival in the current era Transplantation 95 2013 955 959
30. M. Rodriguez-Peralvarez, G. Germani, V. Papastergiou, E. Tsochatzis, E. Thalassinos, and T.V. Luong Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome J Hepatol 58 2013 262 270
31. A.J. Bathgate, P. Hynd, D. Sommerville, and P.C. Hayes The prediction of acute cellular rejection in orthotopic liver transplantation Liver Transpl Surg 5 1999 475 479
32. A.O. Ojo, P.J. Held, F.K. Port, R.A. Wolfe, A.B. Leichtman, and E.W. Young Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940
33. P. Burra, M. Senzolo, A. Masier, H. Prestele, R. Jones, and D. Samuel Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study Dig Liver Dis 41 2009 350 356
34. J.A. Leithead, J.W. Ferguson, and P.C. Hayes Modifiable patient factors are associated with the late decline in renal function following liver transplantation Clin Transplant 26 2012 E316 E323
35. P. Tandon, M. Ney, I. Irwin, M.M. Ma, L. Gramlich, and V.G. Bain Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value Liver Transpl 18 2012 1209 1216
36. A. DiMartini, R.J. Cruz Jr., M.A. Dew, L. Myaskovsky, B. Goodpaster, and K. Fox Muscle mass predicts outcomes following liver transplantation Liver Transpl 19 2013 1172 1180
37. A.J. Montano-Loza, J. Meza-Junco, V.E. Baracos, C.M. Prado, M. Ma, and G. Meeberg Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation Liver Transpl 20 2014 640 648
38. S. Tome, J.T. Wells, A. Said, and M.R. Lucey Quality of life after liver transplantation. A systematic review J Hepatol 48 2008 567 577
39. D.M. Bravata, I. Olkin, A.E. Barnato, E.B. Keeffe, and D.K. Owens Health-related quality of life after liver transplantation: a meta-analysis Liver Transpl Surg 5 1999 318 331
40. K.A. Moore, L.J.R. Mc, and G.D. Burrows Quality of life and cognitive function of liver transplant patients: a prospective study Liver Transpl 6 2000 633 642
41. T. Cowling, L.W. Jennings, R.M. Goldstein, E.Q. Sanchez, S. Chinnakotla, and G.B. Klintmalm Liver transplantation and health-related quality of life: scoring differences between men and women Liver Transpl 10 2004 88 96
42. J. Blanch, B. Sureda, M. Flavia, V. Marcos, J. de Pablo, and E. De Lazzari Psychosocial adjustment to orthotopic liver transplantation in 266 recipients Liver Transpl 10 2004 228 234
43. T. Bianco, U. Cillo, P. Amodio, G. Zanus, A. Salari, and D. Neri Gender differences in the quality of life of patients with liver cirrhosis related to hepatitis C after liver transplantation Blood Purif 36 2013 231 236
44. K. Ruppert, S. Kuo, A. DiMartini, and V. Balan In a 12-year study, sustainability of quality of life benefits after liver transplantation varies with pretransplantation diagnosis Gastroenterology 139 2010 1619 1629 1629, e1611-e1614
45. J. Klein, S.N. Tran, A. Mentha-Dugerdil, E. Giostra, P. Majno, and I. Morard Assessment of sexual function and conjugal satisfaction prior to and after liver transplantation Ann Transplant 18 2013 136 145
46. V. Gomez-Lobo, A. Burgansky, L. Kim-Schluger, and R. Berkowitz Gynecologic symptoms and sexual function before and after liver transplantation J Reprod Med 51 2006 457 462
47. J.K. Ho, H.H. Ko, D.F. Schaeffer, S.R. Erb, C. Wong, and A.K. Buczkowski Sexual health after orthotopic liver transplantation Liver Transpl 12 2006 1478 1484
48. P. Burra, G. Germani, A. Masier, E. De Martin, M. Gambato, and A. Salonia Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure? Transplantation 89 2010 1425 1429
49. P. Burra Sexual dysfunction after liver transplantation Liver Transpl 15 2009 S50 S56
50. I. Brosens, R. Pijnenborg, and G. Benagiano Risk of obstetrical complications in organ transplant recipient pregnancies Transplantation 96 2013 227 233
51. D.M. Rupley, A.M. Janda, S.R. Kapeles, T.M. Wilson, D. Berman, and A.K. Mathur Preconception counseling, fertility, and pregnancy complications after abdominal organ transplantation: a survey and cohort study of 532 recipients Clin Transplant 28 2014 937 945 10.1111/ctr.12393
52. C.S. Coffin, A.A. Shaheen, K.W. Burak, and R.P. Myers Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case-control analysis Liver Transpl 16 2010 56 63
53. N.A. Deshpande, N.T. James, L.M. Kucirka, B.J. Boyarsky, J.M. Garonzik-Wang, and A.M. Cameron Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis Liver Transpl 18 2012 621 629
54. K.D. Watt, R.A. Pedersen, W.K. Kremers, J.K. Heimbach, and M.R. Charlton Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study Am J Transplant 10 2010 1420 1427
55. F. Aberg, M. Gissler, T.H. Karlsen, B.G. Ericzon, A. Foss, and A. Rasmussen Differences in long-term mortality among liver transplant recipients and the general population: a population-based Nordic study Hepatology 61 2015 668 677
56. A. Rubin, C. Sanchez-Montes, V. Aguilera, F.S. Juan, I. Ferrer, and A. Moya Long-term outcome of 'long-term liver transplant survivors' Transpl Int 26 2013 740 750
57. R. Nicolau-Raducu, M. Gitman, D. Ganier, G. Loss, A. Cohen, and H. Patel Adverse cardiac events after orthotropic liver transplantation: a cross-sectional study in 389 consecutive patients Liver Transpl 21 2015 13 21 10.1002/lt.23997
58. K.D. Watt, R.A. Pedersen, W.K. Kremers, J.K. Heimbach, W. Sanchez, and G.J. Gores Long-term probability of and mortality from de novo malignancy after liver transplantation Gastroenterology 137 2009 2010 2017
59. J. Adami, H. Gabel, B. Lindelof, K. Ekstrom, B. Rydh, and B. Glimelius Cancer risk following organ transplantation: a nationwide cohort study in Sweden Br J Cancer 89 2003 1221 1227
60. U. Baccarani, P. Piselli, D. Serraino, G.L. Adani, D. Lorenzin, and M. Gambato Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries Dig Liver Dis 42 2010 55 60
61. D. Collett, L. Mumford, N.R. Banner, J. Neuberger, and C. Watson Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit Am J Transplant 10 2010 1889 1896
62. F. Aberg, E. Pukkala, K. Hockerstedt, R. Sankila, and H. Isoniemi Risk of malignant neoplasms after liver transplantation: a population-based study Liver Transpl 14 2008 1428 1436
63. P. Aseni, M. Vertemati, L. De Carlis, C.V. Sansalone, E. Bonacina, and E. Minola De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation Pathol Int 56 2006 712 715
64. U. Maggi, D. Consonni, M.A. Manini, S. Gatti, F. Cuccaro, and F. Donato Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men PLoS One 8 2013 e65238
65. E. Chak, and S. Saab Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review Liver Int 30 2010 1247 1258
66. W.R. Kim, N.A. Terrault, R.A. Pedersen, T.M. Therneau, E. Edwards, and A.A. Hindman Trends in waiting list registration for liver transplantation for viral hepatitis in the United States Gastroenterology 137 2009 1680 1686
67. S.W. Biggins, K.M. Bambha, N.A. Terrault, J. Inadomi, S. Shiboski, and J.L. Dodge Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma Liver Transpl 18 2012 1471 1478
68. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
69. V. Di Martino, P. Lebray, R.P. Myers, E. Pannier, V. Paradis, and F. Charlotte Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure Hepatology 40 2004 1426 1433
70. M. Berenguer, M. Prieto, J.M. Rayon, J. Mora, M. Pastor, and V. Ortiz Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation Hepatology 32 2000 852 858
71. J.A. Carrion, F. Torres, G. Crespo, R. Miquel, J.C. Garcia-Valdecasas, and M. Navasa Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation Hepatology 51 2010 23 34
72. J.C. Lai, E.C. Verna, R.S. Brown Jr., J.G. O'Leary, J.F. Trotter, and L.M. Forman Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men Hepatology 54 2011 418 424
73. L.S. Belli, A.K. Burroughs, P. Burra, A.B. Alberti, D. Samonakis, and C. Camma Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study Liver Transpl 13 2007 733 740
74. T. Walter, J. Dumortier, O. Guillaud, V. Hervieu, J.Y. Scoazec, and O. Boillot Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center Liver Transpl 13 2007 294 301
75. V. Giannelli, M. Giusto, A. Farcomeni, F.R. Ponziani, M. Pompili, and R. Vigano Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients Transpl Int 25 2012 448 454
76. M.R. Charlton, J.M. Burns, R.A. Pedersen, K.D. Watt, J.K. Heimbach, and R.A. Dierkhising Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 2011 1249 1253
77. B.A. Neuschwander-Tetri, J.M. Clark, N.M. Bass, M.L. Van Natta, A. Unalp-Arida, and J. Tonascia Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease Hepatology 52 2010 913 924
78. R.J. Wong, C. Chou, C.A. Bonham, W. Concepcion, C.O. Esquivel, and A. Ahmed Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data Clin Transplant 28 2014 713 721
79. K. Bambha, P. Belt, M. Abraham, L.A. Wilson, M. Pabst, and L. Ferrell Ethnicity and nonalcoholic fatty liver disease Hepatology 55 2012 769 780
80. J.D. Yang, M.F. Abdelmalek, H. Pang, C.D. Guy, A.D. Smith, and A.M. Diehl Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis Hepatology 59 2014 1406 1414
81. J.M. Clark, F.L. Brancati, and A.M. Diehl Nonalcoholic fatty liver disease Gastroenterology 122 2002 1649 1657
82. S. Kojima, N. Watanabe, M. Numata, T. Ogawa, and S. Matsuzaki Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background J Gastroenterol 38 2003 954 961
83. X. Wang, J. Li, D.R. Riaz, G. Shi, C. Liu, and Y. Dai Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis Clin Gastroenterol Hepatol 12 2014 e391
84. M. Heuer, G.M. Kaiser, A. Kahraman, M. Banysch, F.H. Saner, and Z. Mathe Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience Digestion 86 2012 107 113
85. P. Angulo Nonalcoholic fatty liver disease and liver transplantation Liver Transpl 12 2006 523 534
86. V. Khullar, A. Dolganiuc, and R.J. Firpi Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease World J Transplant 4 2014 81 92
87. U. Becker, A. Deis, T.I. Sorensen, M. Gronbaek, K. Borch-Johnsen, and C.F. Muller Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study Hepatology 23 1996 1025 1029
88. M. Frezza, C. di Padova, G. Pozzato, M. Terpin, E. Baraona, and C.S. Lieber High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism N Engl J Med 322 1990 95 99
89. T. Poynard, P. Mathurin, C.L. Lai, D. Guyader, R. Poupon, and M.H. Tainturier A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 2003 257 265
90. A. DiMartini, N. Day, M.A. Dew, L. Javed, M.G. Fitzgerald, and A. Jain Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease Liver Transpl 12 2006 813 820
91. R. Pfitzmann, J. Schwenzer, N. Rayes, D. Seehofer, R. Neuhaus, and N.C. Nussler Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease Liver Transpl 13 2007 197 205
92. R. Pfitzmann, B. Benscheidt, J.M. Langrehr, G. Schumacher, R. Neuhaus, and P. Neuhaus Trends and experiences in liver retransplantation over 15 years Liver Transpl 13 2007 248 257
93. J. Dumortier, O. Guillaud, M. Adham, C. Boucaud, B. Delafosse, and Y. Bouffard Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center Am J Gastroenterol 102 2007 1032 1041
94. P. Burra, D. Mioni, U. Cillo, S. Fagiuoli, M. Senzolo, and R. Naccarato Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease Transpl Int 13 2000 S174 S178
95. E. Bjornsson, J. Olsson, A. Rydell, K. Fredriksson, C. Eriksson, and C. Sjoberg Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism Scand J Gastroenterol 40 2005 206 216
96. Z. Karim, P. Intaraprasong, C.H. Scudamore, S.R. Erb, J.G. Soos, and E. Cheung Predictors of relapse to significant alcohol drinking after liver transplantation Can J Gastroenterol 24 2010 245 250
97. M.P. Manns, A.J. Czaja, J.D. Gorham, E.L. Krawitt, G. Mieli-Vergani, and D. Vergani Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
98. L. Gronbaek, H. Vilstrup, and P. Jepsen Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study J Hepatol 60 2014 612 617
99. J.H. Ngu, R.B. Gearry, C.M. Frampton, and C.A. Stedman Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study Hepatology 57 2013 2399 2406
100. A.J. Montano-Loza, F. Vargas-Vorackova, M. Ma, V.G. Bain, K. Burak, and T. Kumar Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation Liver Int 32 2012 1426 1433
101. M. Carbone, and J.M. Neuberger Autoimmune liver disease, autoimmunity and liver transplantation J Hepatol 60 2014 210 223
102. J.C. Duclos-Vallee, and M. Sebagh Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation Liver Transpl 15 2009 S25 S34
103. D. Tripathi, and J. Neuberger Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease Semin Liver Dis 29 2009 286 296
104. M.M. Kaplan, and M.E. Gershwin Primary biliary cirrhosis N Engl J Med 353 2005 1261 1273
105. G. Pells, G.F. Mells, M. Carbone, J.L. Newton, A.J. Bathgate, and A.K. Burroughs The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort J Hepatol 59 2013 67 73
106. J.N. Lasker, E.D. Sogolow, L.M. Short, and D.A. Sass The impact of biopsychosocial factors on quality of life: women with primary biliary cirrhosis on waiting list and post liver transplantation Br J Health Psychol 16 2011 502 527
107. W.J. Lammers, K.V. Kowdley, and H.R. van Buuren Predicting outcome in primary biliary cirrhosis Ann Hepatol 13 2014 316 326
108. M. Carbone, G.F. Mells, G. Pells, M.F. Dawwas, J.L. Newton, and M.A. Heneghan Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid Gastroenterology 144 2013 560 569 e567; quiz e513-e564
109. A. Shibuya, K. Tanaka, H. Miyakawa, M. Shibata, M. Takatori, and K. Sekiyama Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis Hepatology 35 2002 1172 1178
110. A. Suzuki, J. Lymp, J. Donlinger, F. Mendes, P. Angulo, and K. Lindor Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis Clin Gastroenterol Hepatol 5 2007 259 264
111. M.G. Silveira, A. Suzuki, and K.D. Lindor Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis Hepatology 48 2008 1149 1156
112. K. Harada, J. Hirohara, Y. Ueno, T. Nakano, Y. Kakuda, and H. Tsubouchi Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan Hepatology 57 2013 1942 1949
113. P. Manousou, V. Arvaniti, E. Tsochatzis, G. Isgro, K. Jones, and G. Shirling Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity Liver Transpl 16 2010 64 73
114. S. Singh, and J.A. Talwalkar Primary sclerosing cholangitis: diagnosis, prognosis, and management Clin Gastroenterol Hepatol 11 2013 898 907
115. E. Toy, S. Balasubramanian, C. Selmi, C.S. Li, and C.L. Bowlus The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population BMC Gastroenterol 11 2011 83
116. K. Boonstra, R.K. Weersma, K.J. van Erpecum, E.A. Rauws, B.W. Spanier, and A.C. Poen Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis Hepatology 58 2013 2045 2055
117. M.B. de Valle, E. Bjornsson, and B. Lindkvist Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort Liver Int 32 2012 441 448
118. K. Friedrich, C. Rupp, J.R. Hov, N. Steinebrunner, K.H. Weiss, and A. Stiehl A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis PLoS One 8 2013 e58734
119. M.T. Mogl, K. Albert, A. Pascher, I. Sauer, G. Puhl, and S. Gul Survival without biliary complications after liver transplant for primary sclerosing cholangitis Exp Clin Transplant 11 2013 510 521
120. E. Alabraba, P. Nightingale, B. Gunson, S. Hubscher, S. Olliff, and D. Mirza A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts Liver Transpl 15 2009 330 340
121. K.J. Moncrief, A. Savu, M.M. Ma, V.G. Bain, W.W. Wong, and P. Tandon The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation - A single-centre experience Can J Gastroenterol 24 2010 40 46
122. A. Vera, S. Moledina, B. Gunson, S. Hubscher, D. Mirza, and S. Olliff Risk factors for recurrence of primary sclerosing cholangitis of liver allograft Lancet 360 2002 1943 1944
123. H. Schrem, M. Kurok, A. Kaltenborn, A. Vogel, U. Walter, and L. Zachau Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection Liver Transpl 19 2013 1252 1261
124. S. Singh, J. Edakkanambeth Varayil, E.V. Loftus Jr., and J.A. Talwalkar Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis Liver Transpl 19 2013 1361 1369
125. J. Sint Nicolaas, V. de Jonge, E.W. Steyerberg, E.J. Kuipers, M.E. van Leerdam, and S.J. Veldhuyzen-van Zanten Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis Am J Transplant 10 2010 868 876
126. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
127. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2010 1 35
128. F. Farinati, A. Sergio, A. Giacomin, M.A. Di Nolfo, P. Del Poggio, and L. Benvegnu Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol 21 2009 1212 1218
129. D. Yang, D.L. Hanna, J. Usher, J. LoCoco, P. Chaudhari, and H.J. Lenz Impact of sex on the survival of patients with hepatocellular carcinoma: a surveillance, epidemiology, and end results analysis Cancer 120 2014 3707 3716 10.1002/cncr.28912
130. S. Cauble, A. Abbas, L. Balart, L. Bazzano, S. Medvedev, and N. Shores United States women receive more curative treatment for hepatocellular carcinoma than men Dig Dis Sci 58 2013 2817 2825
131. A. Cucchetti, M. Cescon, V. Bertuzzo, E. Bigonzi, G. Ercolani, and M.C. Morelli Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant 11 2011 1696 1704
132. R. Senkerikova, S. Frankova, J. Sperl, M. Oliverius, E. Kieslichova, and H. Filipova Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation Transplant Proc 46 2014 1426 1429
133. B. Schlansky, Y. Chen, D.L. Scott, D. Austin, and W.E. Naugler Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study in the UNOS registry Liver Transpl 20 2014 1045 1056 10.1002/lt.23917
134. A. Reuben, D.G. Koch, W.M. Lee Acute Liver Failure Study G Drug-induced acute liver failure: results of a U.S. multicenter, prospective study Hepatology 52 2010 2065 2076
135. R.J. Andrade, M.I. Lucena, M.C. Fernandez, G. Pelaez, K. Pachkoria, and E. Garcia-Ruiz Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521
136. R.J. Fontana Acute liver failure including acetaminophen overdose Med Clin North Am 92 2008 761 794 viii